Two Sigma Securities, LLC
- SEC CIK
- 0001450144
- Latest filing
- Aug 14, 2026
LCTX holding history
Lineage Cell Therapeutics, Inc. in every 13F filed by Two Sigma Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LCTX overviewAll 13F holders of LCTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 37,793
- Value
- $49.5K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 37,793 | $49.5K | <0.1% | +17,403+85.4% | Added | Holders |
| Q1 2026 | 20,390 | $32.2K | <0.1% | −3,208−13.6% | Reduced | Holders |
| Q4 2025 | 23,598 | $39.4K | <0.1% | +23,598 | New | Holders |
| Q3 2025 | 0 | $0 | 0.0% | −18,028−100.0% | Sold out | Holders |
| Q2 2025 | 18,028 | $16.4K | <0.1% | +18,028 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −13,941−100.0% | Sold out | Holders |
| Q3 2024 | 13,941 | $12.6K | <0.1% | +13,941 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −12,704−100.0% | Sold out | Holders |
| Q4 2023 | 12,704 | $13.8K | <0.1% | +12,704 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −16,538−100.0% | Sold out | Holders |
| Q1 2023 | 16,538 | $24.8K | <0.1% | −782−4.5% | Reduced | Holders |
| Q4 2022 | 17,320 | $20.3K | <0.1% | +17,320 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −96,762−100.0% | Sold out | Holders |
| Q3 2021 | 96,762 | $244.0K | 0.1% | +96,762 | New | Holders |